Advertisement

Broad Institute Emerges Victorious In Patent Fight Over CRISPR Gene-Editing Tech

05:15
Download Audio
Resume
Feng Zhang of the Broad Institute of MIT participates in a panel discussion at the National Academy of Sciences international summit on the safety and ethics of human gene editing in 2015 in Washington. (Susan Walsh/AP)
Feng Zhang of the Broad Institute of MIT participates in a panel discussion at the National Academy of Sciences international summit on the safety and ethics of human gene editing in 2015 in Washington. (Susan Walsh/AP)

On Wednesday, the U.S. Patent and Trademark Office ruled that MIT's Feng Zhang and his team of bio-tech scientists at the Broad Institute of MIT and Harvard can keep their patents for their work on CRISPR gene-editing technology.

For more on this ruling and its implications, patent expert Paul Gugliuzza joined Morning Edition.

This segment aired on February 16, 2017.

Related:

Headshot of Bob Oakes

Bob Oakes Senior Correspondent
Bob Oakes was a senior correspondent in the WBUR newsroom, a role he took on in 2021 after nearly three decades hosting WBUR's Morning Edition.

More…

Advertisement

More from WBUR

Listen Live
Close